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 SUMMARY 
Infectious laryngotracheitis (ILT) is a respiratory tract infection of gallinaceous birds, which is 
caused by Gallid herpes virus 1 (GaHV-1), also called infectious laryngotracheitis virus 
(ILTV). In its most virulent form it can cause acute respiratory symptoms such as marked 
dyspnoea, gasping, expectoration of bloody mucus, high mortality (up to 70%) and production 
losses, such as decreased growth and egg production. 
In Sweden, there are regular outbreaks of ILT in hobby flocks with chickens and occasionally 
in other gallinaceous birds, but very few outbreaks have been diagnosed in commercial flocks. 
There are vaccines available and the most commonly used vaccine in Sweden is a live 
attenuated vaccine of chicken embryo origin (CEO). However, vaccination against ILT is not 
routinely practiced in commercial flocks in Sweden but the vaccine is administrated in some 
hobby flocks. In several countries where ILT vaccines are used in commercial flocks there have 
been outbreaks caused by vaccine-related viruses that have regained virulence though mutation 
(so called reversion) or recombined to new viruses, causing clinical outbreaks and production 
losses. The aim of this study was to improve the understanding of the epidemiology of ILT in 
Swedish chicken hobby flocks, including investigating if ILTVs circulating in Sweden are 
related to vaccine viruses. This was done by sequencing parts of the glycoprotein G (gG), 
thymidine kinase (TK) and infected cell polypeptide 4 (ICP4) genes from real time PCR ILTV 
positive nasal swabs from hobby chickens and comparing them to CEO vaccine strains and 
reference strains. These genes have previously been used to differentiate field strains from 
vaccine-related ILTVs. The samples originated from hobby chickens submitted for routine 
diagnostic necropsy with complaints of respiratory signs to the Swedish National Veterinary 
Institute in 2017 and 2018. The samples were also evaluated for co-infection with Avibacterium 
paragallinarum (APG), infectious bronchitis virus (IBV) and Mycoplasma gallisepticum 
(MG). Based on the three partial gene sequences (gG, TK and ICP4) the results suggested that 
the circulating ILTVs in Swedish hobby chickens flocks were related to CEO vaccine virus 
strains, including the vaccine used in Sweden for ILT vaccination. Complete genome data from 
a subset of the samples showed similar results, however, there were additional sequence 
differences in other locations of the genome. Further analyses are needed to determine the level 
of similarity to vaccine strains. The source of these viruses is however unknown. It was 
demonstrated that coinfections with other respiratory pathogens were common in the 
investigated Swedish hobby chicken flocks with ILT outbreaks, with the most common 
pathogen in the investigated ILT affected flocks being APG.  
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 ABBREVATIONS 
Acc. GenBank accession number 
APG Avibacterium paragallinarum 
AIV Avian Influenza Virus 
aPMV-1 Avian Paramyxovirus type 1 (previously known as Avian Avulavirus type 1) 
CEO Chicken Embryo Origin 
ELISA Enzyme-Linked Immunosorbent Assay 
GHV-1 Gallid Herpesvirus 1 
gC, gE, gG  Glycoprotein C, Glycoprotein E, Glycoprotein G 
HSV-1  Herpes Simplex Virus 1 
HVT Herpesvirus of Turkey 
ICP4 Infected Cell Protein 4 
ICP18.5 Infected Cell Protein 18.5 
ILT Infectious Laryngotracheitis 
ILTV  Infectious Laryngotracheitis Virus 
IBV Infectious Bronchitis Virus 
MG Mycoplasma gallisepticum 
MS Mycoplasma synoviae 
ND Newcastle Disease 
ORFB-TK Open reading frame B-thymidine kinase 
ORF C Open Reading Frame C 
ORT Ornithobacterium rhinotracheale 
PCR Polymerase Chain Reaction 
RLFP Restriction Fragment Length Polymorphism 
SVA National Veterinary Institute 
TCO Tissue Culture Origin 
TK Thymidine Kinase 
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INTRODUCTION 
Infectious laryngotracheitis (ILT) is a respiratory tract infection of gallinaceous birds, which is 
caused by Gallid herpes virus 1 (GaHV-1), also called infectious laryngotracheitis virus 
(ILTV). Virulent ILTV can cause acute respiratory symptoms such as marked dyspnoea, 
gasping, expectoration of bloody mucus, high mortality (up to 70%) and production losses, 
such as decreased growth and decreased egg production (Guy & Garcia, 2008). Virulence 
differs between strains. 
In Sweden, there are regular outbreaks of ILT in hobby flocks with chickens, but very few 
outbreaks have been diagnosed in commercial flocks (National Veterinary Institute, SVA, 
2019). There are vaccines available and the most commonly used vaccine in Sweden is a live 
attenuated vaccine of chicken embryo origin (CEO). However, vaccination against ILT is not 
routinely practiced in commercial flocks in Sweden but the vaccine is administrated in some 
hobby flocks. In several countries where ILT vaccines are used in commercial flocks there have 
been outbreaks caused by vaccine-related viruses that have regained virulence from mutation 
(so called reversion) or recombined to new viruses, causing production losses and mortality. 
The aim of this study was to improve the understanding of the epidemiology of ILT in Swedish 
chicken hobby flocks. 
The hypotheses were the following: 
1. The viruses that cause ILT outbreaks in Swedish hobby flocks are genetically variable 
viruses.  




For this literature review, information has been gathered from both textbooks and peer-
reviewed scientific papers. Mostly the Swedish University of Agriculture’s Library’s search 
engine Primo and relevant journal article’s reference lists have been used. Search words were: 
infectious laryngotracheitis, ILT, ILTV, herpesvirus, latency, virulence, immune response, co-
infections, vaccine, vaccination, field virus, vaccine virus, backyard flocks, Sweden, 
sequencing, gG, TK, ICP4, PCR.  
Infectious laryngotracheitis 
Etiology 
Infectious laryngotracheitis virus (ILTV) or Gallid herpesvirus 1 (GHV-1) belongs to the 
family Herpesviridae and subfamily Alphaherpesvirinae and the genus Iltovirus (Davidson et 
al., 2009). 
The genome of the herpesvirus family consists of a linear, double-stranded DNA that is located 
in the core (Knowles, 2011). The viral core is enclosed by a nucleocapsid, which in turn is 
surrounded by a globular matrix called the tegument. The outer layer is a lipid-protein envelope 
with numerous glycoprotein spikes. 
First description 
The disease name infectious laryngotracheitis (ILT) was established by the American 
Veterinary Medical Association, Special Committee on Poultry Diseases in 1931 (Cover, 
1996). The disease laryngotracheitis had already been described in 1925 in Canada and may 
have occurred as early as in 1920. In Sweden, the first known case was described in 1940 in an 
outbreak in Lund, in southern Sweden (Magnusson, 1940).  
Pathogenesis, virulence and immunity 
Most avian herpesviruses have a relatively narrow host range, and so does the ILTV (Trapp & 
Osterrieder, 2008). The chicken is the primary natural host, but pheasants, peafowl and turkeys 
are also susceptible (Guy & García, 2008). Experimentally challenged ducks can be infected 
but develop a subclinical form of the disease. 
The most common way that ILTV is introduced into a flock is by clinically healthy latently 
infected carrier birds shedding the virus, as ILTV can cause a latent state, i.e. a lifelong 
persistent infection (Knowles, 2011). The virus can also be transmitted from clinically affected 
chickens as well as indirectly from contaminated equipment, litter and people (Guy & García, 
2008). The virus is spread with droplets that are inhaled or lands on the conjunctiva, but does 
not spread vertically, i.e. from parent hens through the egg to their progeny. 
When the ILTV enters a host, the virus binds with its outer glycoprotein spikes to receptors on 
the host cell (Knowles, 2011). The virus envelope fuses with the host cell’s plasma membrane 
and the nucleocapsid enters the host cell’s cytoplasm. Then the viral core with the DNA enters 
the host cell’s nucleus, where replication starts.  
The way that ILTV replicates is similar to other viruses in the subfamily Alphaherpesvirinae 
(Guy & Garcia, 2008). Most of the approximately 70 proteins that start to transcribe once in 
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the host nucleus are viral structural proteins, others are proteins including enzymes that regulate 
the viral DNA replication. When the replication of the DNA is complete, it is packed into 
nucleocapsids. The envelope is then formed by budding through the nuclear membrane. Further 
on the virions are pooled in vacuoles in the host cell’s cytoplasm and are released by cell lysis. 
The ILTV invades and replicates in the epithelium of larynx, trachea and other mucus 
membranes such as conjunctiva, nasal mucosa, respiratory sinuses, air sacs and lungs (Guy & 
García, 2008). 
Latency 
As previously stated, the ILTV can cause a latent infection characterized by a subclinical state 
and no virus replication. Williams et al. (1992) suggested the trigeminal ganglion to be the 
predominant site for ILTV latency. This has been confirmed by Oldoni et al. (2009), who 
showed that the virus could be detected as early as two days post infection in the trigeminal 
ganglia. Most knowledge about the establishment of latency has been obtained from the human 
herpes simplex virus (HSV-1), which also belongs to the subfamily Alphaherpesvirinae (Nicoll 
et al., 2011, Thilakarathne et al., 2019). Viruses in this subfamily appear to infect the sensory 
nerve ends in the tissue where the primary infection and virus replication take place. The virus 
is then transported retrogradely to the neuron bodies where it enters the nucleus. In the nucleus 
the viral DNA binds to histones and the lytic gene expression is suppressed and latency is 
established. Reactivation of herpesviruses can occur and is often associated with stress, such 
as the onset of lay and re-housing (Guy & García, 2008). A latent reactivated infection is 
usually asymptomatic but the birds may shed the virus, as having ongoing active replication of 
the virus in the upper respiratory tract. This can lead to infection of susceptible/uninfected 
animals (Trapp & Osterrieder, 2008). 
Immune response 
The most important immune response against ILTV seems to be the local cell-mediated 
response in the upper respiratory tract, and not the humoral response with mucosal antibodies. 
This was shown by Fahey & York (1990) in a study involving drug-induced bursectomised 
chickens (in growing birds, the bursa of Fabricius is necessary for the maturation of B-
lymphocytes). The chickens were ILT vaccinated and then challenged with ILTV. The 
bursectomised chickens cleared the ILT infection as effectively as the intact chickens. This 
shows that the mucosal antibodies do not have a critical role in immunity from vaccination or 
recovery from ILTV infection.  
As in other herpesviruses it is the glycoproteins in ILTV that stimulate both a humoral and a 
cell-mediated immune response (Guy & García, 2008). The glycoprotein G (gG) gene is 
present in most herpesvirus genomes, ILTV included (Coppo et al., 2013a). The gG gene codes 
for a protein that has been demonstrated in some herpesviruses in mammals to be cell-
membrane bound and/or secreted. The secreted protein can function as a chemokine-binding 
protein (Bryant et al., 2003). This means that it can bind to the host’s chemokines and thus 
prevent the chemokines from binding to both its receptors and glucosaminoglycans. The 
binding may inhibit the function of the chemokines and reduce the cell-mediated immune 
response. It suggests that gG has a significant role in the pathogenesis of herpesvirus infection 
(Coppo et al., 2013a).  
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Virulence 
The virulence describes the capacity for the virus to cause disease in a host (Knowles, 2011). 
The term is relative and makes it possible to compare different strains with each other. The 
determinants of virulence are often associated with multiple genes, i.e. several genes contribute 
to the virulence of the virus, which is probably the case in ILTV. For example, Devlin et al. 
(2006) confirmed the gG gene to be an important virulence factor for ILTV, by demonstrating 
that chickens infected with gG deficient viruses had milder clinical signs and greater weight 
gain than chicken inoculated with a wild type virus. Similar results were obtained when 
inoculating an open reading frame C (ORF C) gene-deleted recombinant virus in chickens, 
which suggests that also the ORF C gene is a virulence factor (García et al., 2016).  
Morbidity and mortality 
The morbidity in an infected flock can vary from 5% (mild form) to 90–100% (severe form) 
(Guy & García, 2008). The mortality in a flock can be 0.1–2% for the mild form, while it can 
vary from 5–70% for the severe form. The most common mortality rate for the severe form is 
10–20%.  
Clinical signs 
The incubation period is between 6 and 12 days (Guy & García, 2008). Clinical signs can vary 
from unthriftiness, decreased egg production, watery eyes, conjunctivitis, swelling of 
infraorbital sinuses, persistent nasal discharge, haemorrhagic conjunctivitis to marked dyspnea, 
expectoration of blood-stained mucus and death in the more severe form.   
The recovery time is usually between 10 and 14 days, but in some situations it may take up to 
4 weeks (Guy & García, 2008).  
Pathology 
Gross pathology 
Lesions can be detected in the conjunctiva and the respiratory tract, especially in the larynx 
and trachea (Guy & García, 2008). Depending on the severity of the disease, the lesions can 
vary. In mild cases, conjuctivitis, sinusitis and tracheitis as well as excess mucus in the trachea 
may be observed. In more severe forms there can be diphteric changes with necrotic laryngeal 
and tracheal mucus membranes and/or haemorrhage. This can cause casts consisting of blood 
and exudate that can occlude the larynx or trachea leading to asphyxia (Jansson et al., 2006). 
The inflammation can also extend to the bronchial epithelium, the air sacs and lungs (Guy & 
García, 2008). 
Microscopic pathology 
The microscopic findings depend on the stage and severity of the disease (Guy & García, 2008; 
Trapp & Osterreider, 2008; Jansson et al., 2006). In the early stages of the acute infection there 
are pathognomonic lesions in the conjunctiva, larynx and trachea. These consist of intranuclear 
inclusion bodies in epithelial cells and syncytia (multinucleated cells originating from fused 
ILTV infected epithelial cells). The changes can no longer be observed when the infection 
progresses as a result of necrosis and desquamation.  
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Co-infections and secondary infections 
Co-infections are important factors to take into consideration as they can contribute to ILT 
disease severity and slow recovery (Blakey et al., 2019). As ILT can have a latent state, 
coinfections can potentially be a stress factor that triggers the virus to reactivate.  
There are several infectious microorganisms that can cause respiratory disease in chickens and 
the most important are shown in table 1 (without mutual order) (National Veterinary Institute, 
2019). Further, secondary bacterial infections may occur in birds with ILT. 
Table 1. Infectious respiratory pathogens in poultry 
Mycoplasma gallisepticum (MG, chronic respiratory disease) 
Mycoplasma synoviae (MS) 
Ornithobacterium rhinotracheale (ORT) 
Avibacterium paragallinarum (APG, infectious coryza) 
Avian paramyxovirus type 1 (aPMV-1, Newcastle disease) 
Avian influenza virus (AIV, avian influenza) 
Infectious laryngotracheitis virus (ILTV, infectious laryngotracheitis) 
Infectious bronchitis virus (IBV, infectious bronchitis) 
Aspergillus spp. (aspergillosis) 
Syngamus trachea (gape worm) 
 
Occurrence of respiratory diseases in chicken hobby flocks 
There is limited information on the occurrence of respiratory disease in hobby poultry from 
Sweden and elsewhere. In a study by Blakey et al. (2019) from the USA, it was shown that the 
most common coinfections in hobby flocks with ILT were Mycoplasma synoviae (MS) and 
Mycoplasma gallisepticum (MG).  
In another study from USA, Derksen et al. (2018) showed that the most seroprevalent 
respiratory coinfection in hobby flocks were Ornithobacterium rhinotracheale (ORT, 97.5%), 
avian paramyxovirus type 1 (aPMV-1, 77.5%), infectious bronchitis virus (IBV, 75%), MS 
(75.6%), MG (70.7%), and ILTV (46.3%). They also reported that chickens in hobby flocks in 
close vicinity of a commercial poultry facility were more likely to be seropositive for aPMV-1 
and MG, while chickens in hobby flocks located far from a commercial facility were more 
likely to be seropositive for ORT. The authors suggested that the presence of antibodies in 
chicken close to a commercial facility may be related to the commercial facilities’ vaccination 
protocols. 
High seroprevalence in hobby flocks against respiratory pathogens has also been reported from 
Europe by Haesendonk et al. (2014): ORT 100%, IBV 91.1%, MS 96.4%, MG 73.2%, ILTV 
64.3%; and by Wunderwalt & Hoop (2002): ORT 100%, aPMV-1 17.6%, IBV 92.5%, MS/MG 
82.5%, and ILTV 64.3%. In Finland, Pohjola et al. (2017) demonstrated the seroprevalence for 
respiratory disease in hobby flocks to be lower compared to the above studies (IBV: 47.1%, 
ILTV: 11.8%, aPMV-1: 0%). Information from Sweden on the occurrence of respiratory 
disease in non-commercial poultry is very limited. In a recent report investigating Swedish 
flocks with respiratory complaints (Jansson et al., 2019), ILTV was detected in 62.2%, APG 
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in 66.1% and MG in 54.2% of the flocks. Combination of pathogens was found, the most 
common being MG+APG (23.7%) and MG+APG+ILTV (22.0%).    
Diagnostics 
Infectious laryngotracheitis can be diagnosed based on the pathognomonic histopathological 
changes in the early phase of the disease (Guy & García, 2008; Jansson et al., 2006). This 
method has a high specificity but a low sensitivity as the lesions disappear when the disease 
progresses. Moreover, samples need to be obtained from dead or euthanised birds. If using this 
diagnostic method, several birds from an affected flock should be analysed in the early stage 
of the disease.  
There are several additional ways to diagnose ILT according to the OIE Terrestrial Manual 
(2019). Polymerase Chain Reaction (PCR) and serology e.g. antigen enzyme-linked immuno-
sorbent assay (ELISA), can be used to screen flocks and confirm the presence of ILTV. Virus 
isolation and immunofluorescence are also considered suitable methods. Antibodies may be 
detected with antibody-ELISA and virus neutralisation. 
Treatment 
There is no treatment for ILT (Guy & García, 2008; Jansson et al., 2006). If there is a confirmed 
secondary bacterial infection, antibiotics can potentially relieve signs of disease and shorten 
the course of the disease.  
Outbreaks in Sweden 
The first outbreak of ILT in Sweden was described in a laying hen flock in 1940 (Magnusson, 
1940). From 1959, there were no diagnosed cases until an outbreak occurred in January 1997 
in Dalarna (Jansson et al., 2006; Engström et al., 2011). Since then, there have been outbreaks 
every year. From 1997 to 2011 there were more than 100 outbreaks diagnosed in hobby flocks 
across the country and only a very few in commercial flocks. The number of outbreaks is 
probably much higher than the reported cases (Jansson et al., 2006). 
A large majority of the ILT outbreaks in Sweden occur in hobby flocks (National Veterinary 
Institute, SVA, 2019). The outbreaks vary in severity, which is likely associated with different 
levels of virulence of the virus, management, current immune status of the flock and occurrence 
of respiratory coinfections (Jansson et al., 2006). In the most severe cases, Swedish hobby 
flock owners have reported a rapid disease progression in the entire flock with mortality up to 
75%. In milder cases owners have reported a slower disease progression with milder symptoms. 
It is assumed that the virus is mainly transmitted by latently infected clinically healthy 
chickens, often as a result of trading. Outbreaks have also occurred after poultry shows. 
Outbreaks in commercial flocks have been demonstrated in four cases, which occurred between 
2007 and 2013 (National Veterinary Institute, SVA, 2019). Apart from these outbreaks, the 
commercial sector is considered free from ILTV. 
In 1999 the National Board of Agriculture in Sweden changed the status of ILT from being 
classified as an epizootic disease to a notifiable disease (National Veterinary Institute, SVA, 
2019), which means that the disease is not included in an eradication policy. The decision was 
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based on serological results that suggested the virus to be endemically established in Sweden 
and that chances of eradication were small.  
Vaccination against ILT 
Type of ILT vaccines 
There are two commercially available types of approved vaccines against ILT, live-attenuated 
vaccines and recombinant viral vectored vaccines (review by García & Zavala, 2019). There is 
also potential new vaccines being developed, most of these are recombinant gene-deleted 
attenuated vaccines. 
Live attenuated vaccines 
To prepare a live attenuated vaccine several virus sources can be used. For ILTV the virus is 
attenuated by repeated passages through either chicken embryos (CEO, chicken embryo origin) 
or in tissue culture (TCO, tissue culture origin) (García, 2016). During each passage nucleotide 
substitutions (mutations) accumulate as the virus adapts to replicate in an embryo or a cell 
culture, which leads to reduced virulence (MacLachlan & Dubovi, 2011). 
 Transmission and regaining of virulence 
The CEO and the TCO vaccines are effective in reducing the clinical ILT signs in chickens, 
but they do not prevent infection, virus replication and transmission of the virus (Guy et al., 
1991, Rodríguez-Avila, 2007). This means that the vaccine virus (and wild-type viruses) can 
still infect the birds and be transmitted to other birds as well as establish a latent infection. 
Further, as transmission is not prevented by vaccination, the bird-to-bird (in vivo) passage in a 
flock can allow the CEO vaccine virus to regain its virulence, a process called reversion (Guy 
et al., 1991). This can cause disease outbreaks if the vaccine virus is spread to unvaccinated 
birds due to insufficient biosecurity measures, mixing of vaccinated and unvaccinated birds or 
if vaccine administration is done incorrectly, leading to a situation where not all birds in the 
flock have developed immunity.  
Several outbreaks of ILT have been genetically associated to a vaccine virus (Blakey et al., 
2019; Coppo et al., 2013b; García & Zavala, 2019; Menendez et al., 2014; Moreno et al., 2010; 
Neff et al., 2008; Ojkic et al., 2006).  
In USA, Blakey et al. (2019) sequenced the infected cell protein 4 (ICP4) gene in 15 samples 
from hobby flocks that were ILTV positive by real time-PCR. Nine of these were 100% 
identical to a CEO vaccine strain, and five were 98.8% identical. Neff et al. (2008) analysed 
virus isolates with PCR and restriction fragment length polymorphism (RFLP), and sequencing 
of the thymidine kinase (TK) gene. Isolates were extracted from 104 samples from outbreaks 
of ILT in Western Europe during the years 1973–2006, including early isolates from Sweden. 
The analyses revealed that the majority of western European isolates (98 of 104 samples in 
total) were related to vaccine strains. Of the 104 isolates, 14 isolates came from hobby flocks 
in Sweden, of which 13 had genetic similarity to the vaccine strains, despite that they had been 
collected prior to the start of vaccination in Sweden (Jansson, D., personal communication 
2019). One Swedish isolate differed in RFLP pattern and was considered to be one of the wild-
type strains circulating in Europe, although limited in regional spread and number of infected 
cases. In another study, Ojkic et al. (2006) investigated ILT outbreaks in Ontario, Canada. Here 
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as well it was demonstrated that some of the included isolates were genetically related to 
vaccine strains. García & Zavala (2019) recently reported that there are currently four main 
viral genotypes that are considered to cause ILT outbreaks in the USA, of which three are 
closely related to live attenuated vaccines.  
 Recombination of vaccine strains 
There is also a possibility that vaccine viruses can recombine with each other and with wild-
type ILTVs and create new virulent field strain. This has been reported from Australia (Lee, 
2012) where new classes of viruses have started to circulate when a live attenuated vaccine 
from Europe was introduced. Further, Agnew-Crumpton et al. (2016) demonstrated that one of 
the new virus classes had replaced the previous dominant classes of viruses in some regions in 
Australia and seems to be more virulent than previous circulating virus classes.  
Recombinant viral vector vaccines  
As there is a risk for the attenuated live vaccine viruses to regain virulence, there has been a 
new generation of vaccines developed for chickens: recombinant viral vector vaccines (reviews 
by García & Zavala, 2019; Coppo et al., 2013b). For ILT there are two types of recombinant 
viral vector vaccines that are commercially available.  
The principle behind recombinant viral vector vaccines is to insert one or several genes (in this 
case from the ILT genome) coding for antigens that stimulate an immune response, into a 
genome of another DNA virus, i.e. the vector (MacLachlan & Dubovi, 2011).  
Recombinant viral vector vaccines against ILT have been shown in several studies to reduce 
the severity of clinical signs of ILT and improve the birds’ performance (reviews by Coppo et 
al., 2013b; García & Zavala, 2019). They are however not as effective as the live attenuated 
CEO vaccines in terms of reducing shedding of challenge virus (Johnson et al., 2010). 
Recombinant gene-deleted live attenuated ILTV vaccines 
There is a potential new type of vaccine against ILT, recombinant gene-deleted live attenuated 
ILTV vaccines (García, 2016). In this type of vaccine non-essential genes that contribute to 
virulence are deleted from the genome of the vaccine virus candidate (MacLachlan & Dubovi, 
2011). An advantage is the possibility to differentiate serologically between vaccinated and 
unvaccinated birds (differentiating infected from vaccinated animals, DIVA, strategy), if the 
protein that the deleted gene is coding for can be used as a capture antigen in ELISA.  
The most extensively investigated candidate for a recombinant gene-deleted live attenuated 
vaccine for ILT is the ∆gG ILTV vaccine strain, where the virulence factor gene gG has been 
deleted (Korsa et al., 2018).  
Vaccination strategies and control of the disease 
Disease control is based on biosecurity, management and vaccination (García & Zavala, 2019). 
In countries where vaccination is used against ILT, vaccination is commonly done to prevent 
and control disease in breeders, layers, broilers and hobby flocks (review by Menendez et al., 
2014; National Veterinary Institute, SVA, 2019). Although new vaccine types have become 
available, the live attenuated CEO vaccines are still being used to get the highest disease 
protection in USA, Europe and Asia (review by García & Zavala, 2019). It is a common 
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practice in commercial flocks to administer a combination of vaccines during the life span of a 
flock depending on the needs of the producer and what is permitted in the country. As an 
example, in USA, commercial layer flocks can receive a subcutaneous vaccination at one day 
of age with a recombinant viral vector vaccine and then be revaccinated with a CEO or TCO 
vaccine at between 8–12 weeks of age to protect birds from ILT. 
In Sweden, an outbreak of ILT on a multi-age laying hen farm in 2007 was eliminated with the 
help of vaccination and various biosecurity measures, such as manure storage in closed houses, 
change in delivery schedules to the farm and cleaning and disinfection of transport vehicles 
(Engström et al., 2011).  
Administration routes 
There is a variety of administration routes for ILTV vaccines including eye drop, coarse spray, 
in drinking water, subcutaneous injection, wing web application and in ovo injection. Drinking 
water and coarse spray are most commonly used in commercial flocks as mass vaccination is 
easy to perform at low cost (reviews by Coppo et al., 2013b and Menendez, 2014).  
As TCO vaccines must be administered through eye drop to each bird, this is not as commonly 
used as the CEO vaccines (review by Menendez et al., 2014). If the TCO is administered as a 
mass vaccination, for example in drinking water, the level of immunity may be insufficient in 
a subset of the birds, which may increase the risk for reversion to more virulent vaccine strains 
(M. García, pers. comm. in García & Zavala, 2019). 
ILT vaccination in Sweden 
Vaccination against ILT of commercial poultry is not routinely practiced in Sweden (National 
Veterinary Institute, SVA, 2019). As mentioned earlier, there has been one case of vaccination 
in a commercial flock, as a measure to eliminate an ILT outbreak (Engström et al., 2011; 
National Veterinary Institute, SVA, 2019). Vaccination of hobby flocks started in 2006 due to 
an increased number of outbreaks and in response to the wishes of individual poultry owners. 
Two different CEO vaccines have been used (personal communication D. Jansson, National 
Veterinary Institute, SVA, Uppsala, Sweden, 2019): 
- AviPro ILT; Lohmann Animal Health; Hudson strain (Menendez et al., 2014) 
- Nobilis ILT; Intervet/MSD Animal Health; Serva strain (Menendez et al., 2014) 
AviPro ILT was used from 2006 to around 2014, when it was replaced with Nobilis ILT. The 
use of Nobilis ILT is licensed to the National Veterinary Institute (SVA) and a prescription 
from a veterinarian is necessary for a hobby flock owner to get access to the vaccine. The 
vaccination of hobby flocks in Sweden is voluntary. The vaccine is administered by the bird 
owners as an eye drop vaccine. 
Virus strains 
Vaccine virus and wild-type virus 
The CEO vaccines were developed from field viruses in the 1950s and the 1960s (Menendez 
et al., 2014). Today the following vaccine strains are still in use: Cover, Hudson, Samberg, A2, 
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A20 and Serva strain. The vaccine strains originate from USA (Cover and Hudson), Israel 
(Samberg), Australia (A2 and A20) and Europe (Serva).   
As all ILTVs belong to the same serotype, it is not possible to separate infection with field 
viruses from vaccine viruses with diagnostic assays based on antigenic differences (Menendez 
et al., 2014; Coppo et al., 2013b). Instead, molecular analysis is necessary, such as RFLP and 
DNA sequencing. These methods use the multilocus genotyping schemes targeting various 
combinations of genes. The genes targeted for sequencing vary depending on the geographic 
region (Menendez et al., 2014). In Europe the gG, TK, ICP4, glycoprotein E (gE), open reading 
frame B-thymidine kinase (ORFB-TK) and infected cell protein 18.5 (ICP18.5) genes have 
been used for characterisation of field isolates and vaccine strains (Neff et al., 2008; Moreno 
et al., 2010).  
Complete genome sequencing 
Complete genome sequencing of ILT vaccine viruses and field isolates can be done to provide 
data on genetic variation (Menendez et al., 2014). This can make it possible to compare and 
associate for example the level of attenuation with nucleotide changes (Coppo et al., 2013b). 
Complete genome sequencing can also be used to systematically describe virus genotypes that 
are present in an area or country. 
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MATERIALS AND METHODS 
Study population 
Owners of hobby flocks have a possibility to submit dead or euthanized chickens for routine 
diagnostic necropsies to SVA. The samples used in this study came from such chickens. The 
enclosed limited medical history provided by the flock owners indicated that most flocks had 
a moderate to severe outbreak of respiratory disease with mortality at the time of submission. 
However, detailed clinical information was not available, including development of clinical 
signs and mortality rates in later stages of the outbreaks. In a majority of the cases included in 
this study, ILT was confirmed by histopathology and in some cases ILTV was detected by real 
time-PCR. The chickens were submitted during 2017 and 2018. Cases were those from which 
samples where available for further analysis and are named as 17-ALDXXXXX or 18-
ALDYYYYY, where 17 and 18 represents the year, ALD is the laboratory code followed by a 
unique sample number. 
Samples (swabs from the nasal cavity or trachea from the necropsied chickens) originated from 
29 flocks with confirmed ILT outbreaks. Of these, 13 flocks were sampled in 2017 and 16 in 
2018. The chickens were submitted from different parts of Sweden (Table 2). There were 27 
chickens submitted in 2017 and 39 in 2018, with a total of 21 swabs available from 2017, and 
36 swabs from 2018.  
Table 2. Number of flocks per region (county) in 2017 and 2018 that were included in this study. The 
numbers in brackets represents number of submitted chickens per flock. 
County 2017 2018 
Skåne 3 (1,3,1) 1 (3) 
Halland 1 (2) 1 (3) 
Östergötland 2 (4,2) 1 (2) 
Stockholm 2 (3,2)  4 (4,2,2,2) 
Västra Götaland 3 (2,1,2) 3 (1,3,2) 
Västmanland 1 (3) 1 (3) 
Gästrikland/Hälsingland 1 (1) 1 (3) 
Dalarna 0 1 (3) 
Närke 0 1 (1) 
Södermanland 0 1 (3) 
Småland 0 1 (2) 
 
There was no information if the flocks were vaccinated against ILT or not. The laboratory work 




Extraction of nucleic acid 
Nucleic acids were extracted using Viral NA Magnetic Beads kits in an ArrowTM 2 extraction 
robot (DiaSorin, Saluggia, Italy). For the extraction, 250 µL of transport media was added to 
separate 1.2 mL Eppendorf tubes together with 10 µL ≥800 U/mL proteinase K (Sigma-
Aldrich, Saint Louis, MO, USA), and run in the extraction robot according to the 
manufacturer’s recommendations. Positive and negative controls were included in each 
extraction. The vaccine used in Sweden, Nobilis ILT, was used as the positive control. The 
other vaccine that has been used in Sweden (AviPro ILT) was not available for analysis.   
Real time PCR 
The presence of ILTV DNA in the extracted samples (including positive and negative controls) 
was determined by real-time PCR ILTV assay, as described previously by Callison et al. 2007. 
Primers and probes were designed based on a conserved region of the glycoprotein C (gC) 
gene. The assay was customised using an AgPath-ID One-Step RT-PCR kit (Applied 
Biosystems, ThermoFisher Scientific) that is routinely in use.  
To screen for co-infections, all samples were analysed for APG, IBV and MG nucleic acid by 
real time-PCR. Previously published primer and probe sequences targeting the GTP-binding 
protein (yihA) genes of APG (Corney et al., 2008), the 5′-untranslated region of IBV (Callison 
et al., 2006) and the CTP synthetase (pyrG) and the cytadhesin (mgc2) gene of MG (Sprygin 
et al., 2010) were used for specific detection of the respective pathogen. Positive and negative 
controls were used. 
Sequencing  
Choice of genes and primer design 
The TK, gG and ICP4 genes were selected for amplification and sequencing as these genes can 
help to differentiate virus strains, as previously described (Neff et al., 2008; Moreno et al., 
2010; Menendez et al., 2014). The gG gene codes for a glycoprotein on the surface of the virion 
(Devlin et al., 2006), while the TK gene codes for an enzyme that catalyses one of the reactions 
involved in the DNA synthesis (Coppo 2013b). The ICP4 is a major regulatory protein of gene 
expression during the early infection phase (Johanson et al., 1995). These genes have 
conserved regions, which means that they have not changed during natural selection and have 
a similar DNA sequence across strains, which is an advantage when detecting any differences 
in the sequences (Johnson et al., 1995; Griffin & Boursnell, 1990; Devlin et al., 2006). There 
are many sequences to use for comparison in the GenBank database. GenBank is an online 
database that is built and distributed by the United States National Institute of Health and has 
gathered all publicly available DNA sequences (Benson et al., 2013).  
Primers targeting the gG and TK genes were designed by S. Zohari, Department of 
Microbiology, SVA, Sweden (2010) and primers used for ICP-4 were according to Madsen et 
al., 2013 (Table 3).  
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Table 3. Primers used with sequence 
Gene Name of primer Forward (F)/ Reverse (R) Sequence 
gG ILTgG-F58 F 5'-gtaactgactacgcatc-3' 
gG ILTgG-R1165 R 5'-ttagcaacagacacgca-3' 
TK ILT-TKIP-F4614 F 5'-cttagcggaacctatgcaag-3' 
TK ILT-TKIP-R5273 R 5'-tagcgtctggtcgattgaag-3' 
ICP4 ILTV-ICP4-1F-Madsen2013 F 5'-actgatagcttttcgtacagcacg-3' 
ICP4 ILTV-ICP4-1R R 5'-catcgggacattctccaggtagca-3' 
ICP4 ILTV-ICP4-2F-Madsen2013 F 5'-cagaggaccagcaaagac-3' 
ICP4 ILTV-ICP4-2R R 5'-ctaactgttccactggcatc-3' 
 
Conventional PCR 
Amplification by conventional PCR targeting the gG and TK genes (all samples) and the ICP4 
gene (13 samples selected based on geographic origin and year) was done according to the 
method routinely used at the Department of Microbiology, SVA, Sweden. PCR products were 
separated by gel electrophoresis in Lonza FlashGelTM DNA kits according to the 
manufacturer’s instructions. A DNA molecular weight marker as well as a positive control was 
loaded on each gel (Figure 1).  
 
Figure 1. Example of product of gel electrophoresis. Well number 5 is negative and well numbers 1-4 
and 6-12 are positive. Well number 13 contains the DNA marker. Numbering from the left to the right 
side of the picture. 
Sanger sequencing with capillary electrophoresis 
Sequencing of the PCR products for gG, TK, ICP4 and positive control (CEO vaccine Nobilis 
ILT) was performed. The PCR products were cleaned with FastAPTM Thermosensitive 
Alkaline Phosfatase and Exonuclease I (Thermo Fisher Scientific Inc.), followed by cycle 
sequencing with a BigDye® Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems Art.). 
Further, sequencing clean up was done with a Montage SEQ96 sequencing Reaction Cleanup 
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kit (EMD Millipore Corp) before the capillary electrophoresis in a 3500 Genetic Analyser from 
Applied Biosystems, Hitatchi. Each analysed sample resulted in a chromatogram and a DNA 
sequence. All procedures were done according to the manufacturer’s recommendations.   
Processing of DNA sequencing products 
Editing of chromatograms and assembly of nucleotide sequences was performed in the free 
software ”BioEdit Sequence Alignment Editor” (Informer Technologies Inc, 2020). The 
sequences were aligned with reference sequences from the GenBank database in the online tool 
BLAST® (U.S. National Library of Medicine, 2019) to receive phylogenetic information. 
Commonly used vaccine strains were used as reference strains as well as field strains selected 
based on similarity with study samples and relation with vaccine strains. 
Alignment of multiple sequences and phylogenetic analysis of the obtained gG, TK and ICP4 
gene sequences were done in the free software “Mega – Molecular Evolutionary Genetics 
Analysis” version 6 (Tamura et al., 2013) and version X (Kumar et al., 2018) Phylogenetic 
reconstruction was done using maximum likelihood (Tamura-Nei) analysis with bootstrap 
values expressed as percentage of 1000 replications.  
Next generation sequencing 
The complete genome was sequenced for four samples. Selection was based on virus 
concentration and geographic location. The samples represented four different regions and had 
been obtained in 2017 and 2018. There was no known epidemiological link between the flocks 
of origin. The sequencing was done with a next generation sequencing (NGS) system: library 
preparation with a Nextera XT DNA Library Prep kit (Illumina) followed by sequencing with 
a MiSeq Reagent Kit v3 600 cycles (Illumina). Quality control was done before sequencing 
with an Aglient High Sensitivity DNA kit on a Bioanalyzer 2100 (Agilent Technologies).  
Alignement as well as phylogenetic information, analysis and reconstruction were done as 




Real time PCR 
ILTV 
ILTV was detected by real time-PCR in 52 out of 57 samples (21 samples from 2017 and 31 
samples from 2018), which corresponds to 51 out of 54 birds (21 birds in 2017 and 30 birds in 
2018). The five negative samples in 2018 came from two flocks, where there was a real time-
PCR positive sample from at least one other bird in the same flock. Out of the 52 positive 
samples there were 4 samples with a ct value over 30, which is considered less reliable as the 
virus concentration is low.  
Co-infections 
Out of the 29 sampled flocks, 8 flocks (28%) had one or more chickens that were confirmed 
MG positive by real time-PCR (4 flocks in 2017 and 4 flocks in 2018); 25 flocks (86%) were 
confirmed APG positive in one or more chickens (10 flocks in 2017 and 15 flocks in 2018) and 
8 flocks (28%) had chickens positive for IBV (4 flocks in 2017 and 4 flocks in 2018).  
Of the 54 sampled chickens, 15 (28%) were confirmed MG positive by real time-PCR (7 
chickens in 2017 and 8 chickens in 2018); 47 (87%) were confirmed APG positive (15 in 2017 
and 32 in 2018) and 11 (20%) were confirmed IBV positive (5 in 2017 and 6 in 2018) (Table 
4).  
Table 4. Percentage of flocks and chickens confirmed positive by real time-PCR for MG, APG or IBV 
Pathogen Number (%)  
positive flocks 
Number (%)  
positive chicken 
MG 28 28 
APG 86 87 
IBV 28 20 
 
c-PCR 
The PCR products amplified for the gG, TK, ICP4-1 and ICP4-2 genes were detected as a DNA 
band on gelelectrophoresis of approximately 1200 bp, 650 bp, 700 bp and 600 bp respectively. 
The gG and TK DNA band were weak for six and one sample, respectively, and no visible 
band for three and one sample, respectively. 
Sequencing of the gG, TK and ICP4 genes 
gG gene 
Fifty-two samples and the positive control (Nobilis ILT vaccine) were sequenced for a part of 
the gG gene. Seven samples were not included in the final analysis due to lack of sequence 
quality (one of these samples was 18-ALD003986, see TK gene below). The gG sequence that 
was aligned extended from nucleotide position 131023 to 132025 (1003 bp) in the ILTV 
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genome strain 4787/80 (GenBank accession number (acc.) KP677885.1). Four complete ORFs 
were found from nucleotide position 53 to 930, 526 to 930, 715 to 930 and 745 to 930. 
Computer analysis showed a 100% nucleotide identity both between samples and the Nobilis 
ILT vaccine (sequenced in this study) in the aligned sequence, except for four samples (Table 
4). For these samples, single nucleotides could not be completely confirmed: four in 17-
ALD000302 (position 592, 747, 754 and 909), two in 17-ALD007245 (position 687 and 909), 
two in 18-ALD003193 (position 840 and 971) and one in 17-ALD008418 (position 861). 
Further, sample 17-ALD007245 differed in one nucleotide in position 861 (C to T), this led to 
no change in amino acid. Sample 18-ALD003193 differed in two nucleotides in position 972 
(T to C) and position 978 (C to G). This led to change in amino acid to an unknown amino acid 
(position 972) and a change from cysteine to tryptophan (position 978). For position 840 in 18-
ALD003193, if C to T there would be no change in amino acid, but if C to G, the amino acid 
would change from cysteine to tryptophan. 
The sequences were also compared with commonly used vaccine strains from other countries 
(Table 5). 41 samples showed a 100% nucleotide identity. The four samples that differed 
showed a 99.6–99.9% nucleotide identity with the vaccine strains.  
Table 5. Results of partial sequencing of the gG gene. Numbers show single nucleotide positions with 
polymorphisms. Polymorphic positions are highlighted in bold. An asterisk (*) represents the same 
nucleotide as in the row titled Shared sequence of 41 samples. Reference vaccine strains are Nobilis 
ILT (sequenced in this study), LT Blen (acc. JQ083493.2), LaryngoVac (acc. JQ083494.2) and live 




592 687 747 754 840 861 909 971 972 978 
Shared sequence of 41 
samples 
T C G C C C G C T C 
17-ALD000302 A/T * G/T A/C * * G/C * * * 
17-ALD007245 * C/T * * * T G/C * * * 
18-ALD003193 * * * * G/T * * C/T C G 
17-ALD008417 * * * * * C/T * * * * 
Vaccines:           
Nobilis ILT * * * * * * * * * * 
Laryngo-Vac * * * * * * * * * * 
LT Blen * * * * * * * * * * 





Fifty-two samples and the positive control Nobilis ILT vaccine were sequenced for a part of 
the TK gene. The TK sequence that was aligned extended from nucleotide position 33607 to 
34234 (628 bp) in the ILTV genome strain 4787/80 (acc. KP677885.1). No complete ORFs 
were found in the TK sequence. 
Computer analysis showed a 100% nucleotide identity between samples in the aligned 
sequence, except for two samples and the Nobilis ILT vaccine (sequenced in this study), that 
differed by one nucleotide each. Sample 18-ALD002339 in position 601 (C to T), this led to a 
change in amino acid threonine to isoleucine. Sample 18-ALD003986 in position 347 (T to C), 
this led to no change in amino acid. The same nucleotide change as in 18-ALD003986 was 
found in the Nobilis ILT vaccine.  
When compared to GenBank retrieved vaccine strains from other countries (LT Blen, acc. 
JQ083493.2; LaryngoVac, acc. JQ083494.2; live attenuated Serva strain, acc HQ630064.1), 
the same nucleotide change as in 18-ALD003986 and Nobilis ILT vaccine was seen. The 
nucleotide identity for the vaccine strains was 100% for 18-ALD003986, 99.6% for 18-
ALD002339 and 99.8% for the remaining 50 samples. 
ICP4 gene 
Thirteen samples and the positive control Nobilis ILT vaccine were sequenced for a part of the 
ICP4 gene. The ICP4 sequence that was aligned extended from nucleotide position 146998 to 
148032 (1035 bp) in ILTV genome strain 4787/80 (acc. KP677885.1). Three complete ORFs 
were found, from nucleotide position 305 to 613, 668 to 838 and 802 to 1035. 
Computer analysis showed a 100% nucleotide identity between samples in the aligned 
sequence, except for one sample (18-ALD002509) that had one additional nucleotide (a C) 
inserted at position 11. 
When compared to GenBank retrieved vaccine strains from other countries (LT Blen, acc. 
JQ083493.2 and live attenuated Serva strain, acc HQ630064.1) there was a 100% nucleotide 
identity for 12 of the samples. For 18-ALD002509 there was a 99.9% nucleotide identity. 
Sequence analyses 
Figure 2 shows the genetic relationship for the combined gG and TK genes; and Figure 3 for 
the combined gG, TK and ICP4 genes.  
The dendrogram grouped the nucleotide sequences, where the study samples are in one group 
and the vaccine strains are in another group. Bootstrap value is 62%. 
Reference strains included in the dendrograms (Fig. 2–4) were complete genomes from 
GenBank available for all three gene parts and the complete genome analysis. They were 
selected based on relation to vaccine virus (wild type viruses: Rus/Ck/Penza/2013/270, acc. 
MF405080.1 and 4787/80 Italy, acc. KP677885.1; vaccine related virus: 40798/10/Ko Korea, 
acc. MH937566.1) and similarity with study samples. The USDA reference (acc. JN542534.1) 
was selected as an outgroup in the complete genome analysis (Fig. 4) and were also included 
in Figure 2 and 3 for uniformity. 
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Fig. 2. Genetic relationship of the combined gG and TK sequences for 14 samples, reference strains 
and vaccine strains. The partial gene sequences were aligned with the Nobilis ILT vaccine strain 
sequences (sequenced in this study) and GenBank retrieved reference strains (40798/10/Ko Korea, 
related to vaccine strain, acc. MH937566.1; Rus/Ck/Penza/2013/270, acc. MF405080.1; 4787/80 
Italy, acc. KP677885.1 and the USDA reference, acc. JN542534.1) and vaccine strains (LT Blen, acc. 
JQ083493.2 and live attenuated Serva strain, acc. HQ630064.1 and LaryngoVac, acc. JQ083494.2). 
 
 
Fig. 3. Genetic relationship of the combined gG, TK and ICP4 sequence for 13 samples, reference 
strains and vaccine strains. The partial gene sequences were aligned with the Nobilis ILT vaccine 
strain sequences (sequenced in this study) and GenBank retrieved reference strains (40798/10/Ko 
Korea, related to vaccine strain, acc. MH937566.1; Rus/Ck/Penza/2013/270, acc. MF405080.1; 
4787/80 Italy, acc. KP677885.1 and the USDA reference, acc. JN542534.1) and vaccine strains (LT 
Blen, acc. JQ083493.2 and live attenuated Serva strain, acc. HQ630064.1).  
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Complete genome sequencing 
Each of the four complete genome sequences made from field viruses in the samples were 
aligned with their respective gG and TK sequences. As only 13 samples were sequenced for 
the ICP4 gene, the ICP4 sequence aligned was not from the same sample as the complete 
genome except for one sample. The aligned sequences showed a 100% nucleotide identity. 
Figure 4 shows the genetic relationship for the full genome for the four samples. The 
dendrogram grouped the nucleotide sequences into three clades (A, B and C) where the four 
study sequences and two reference sequences are in clade A, the vaccine strains and one 
reference strain (related to vaccine strains) are in clade B and one reference strain is in clade 
C. The nucleotide identity was 96.3% (USDA reference) and between 99.8-99.9% for the 
remaining reference strains.  
 
Fig. 4. Genetic relationships of the complete ILTV genome from 4 samples, reference vaccine strains 
and reference strains. Full genomes used for the analyses were:17-ALD002581,18-ALD001429, 18-
ALD002339 and 18-ALD003873 from the present study and GenBank retrieved vaccine strains and 
reference strains (LT Blen, acc. JQ083493.2; LaryngoVac, acc. JQ083494.2; Nobilis Laringovac, 
acc. KP677881.1; Poulvac, acc. KP677882.1; strain 4787/80 Italy, acc. KP677885.1; strain 
Rus/CK/Penza/2013/270, acc MF405080.1, the Korean vaccine related strain 40798/10/Ko, acc. 
MH937566.1 and the USDA reference, acc. JN542534.1). Clades are designated as A, B and C.  
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DISCUSSION 
This study investigated both the genetic variation and relation to vaccine strains in samples 
from ILTV outbreaks in 2017 to 2018 in chicken hobby flocks in Sweden. Respiratory co-
infections were also assessed. The aim was to improve the understanding of the ILT 
epidemiology in Sweden. The samples were analysed by PCR to detect ILTV and partial 
sequences of three genes previously used to assess similarity to vaccine-related viruses 
obtained. Complete genome sequences were determined from four samples. 
Field virus versus vaccine virus 
From the analyses of the partial sequences of the gG, TK and ICP4 genes it appears that the 
ILT virus strains circulating in Sweden during 2017–2018 were vaccine-like strains, as the 
sequences from samples obtained during clinical ILT outbreaks showed a sequence similarity 
of at least 99.6% to vaccine virus strain. This assumption confirms the results from a study by 
Neff et al. (2008) that suggested that most viruses circulating in Swedish hobby flocks during 
the first years of the return of ILT in this population of chickens and prior to the use of ILT 
vaccines in Sweden were related to live attenuated vaccine strains. 
When comparing the partial TK gene sequence from Neff et al. (2008; GenBank acc. 
EU360946) that belonged to the same clone (1, CH04) as the Swedish isolates in the same 
study, with the part that overlaps the partial TK gene sequenced in this study, it was identical 
in 50 out of 52 samples. The partial TK gene in vaccine strains from the same study were 
identical with our sample 18-ALD003986 and the vaccine used in Sweden, ILT Nobilis, also 
sequenced in the present study. This indicates that it might be the same virus that circulated in 
Sweden in 2017–2018, as during the years 1998–2006 when the samples used in Neff et al. 
(2008) were obtained. However, this assumption is based on only one sequence from the TK 
gene. It would be interesting to investigate whether our samples have the same cleavage pattern 
as the samples in Neff et al. (2008) if conducting an RLFP analysis. 
In previous publications, reviewed by Menendez et al. (2014), the method of choice to 
differentiate strains has until recently been multi-locus RLFP, which is now steadily replaced 
with DNA sequencing of combinations of genes or whole genome sequencing. It has been 
shown that if two separate regions of the ICP4 gene are sequenced in field viruses and 
compared with vaccine viruses, it is possible to differentiate between ILTV field and vaccine 
strains (Chacón & Ferreira, 2009). The present study sequenced parts of three genes that have 
been used earlier to differentiate field and vaccine viruses (gG, TK and ICP4 genes). When 
combining the gG, TK and ICP4 gene the dendrograms (Fig. 3 and 4) separated the study 
samples and vaccine strains into different groups. The bootstrap value was however quite low 
(62%) for separating the vaccine strains in a different group. When analysing the genes 
separately, vaccine strains fell into the same group as study samples for the gG and ICP4 
sequences. For the TK sequence the samples and vaccine strains are separated into two groups, 
except for sample 18-ALD003986 that is grouped together with the vaccine strains. This 
indicates that it is the differences in the TK gene that separated the study samples and vaccine 
strains into different groups when combining all three genes together. As the difference is only 
one nucleotide, this strengthens the assumption that the majority of ILT viruses analysed in this 
study were vaccine-like strains. 
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When aligning and comparing the complete genome of four samples from this study with 
complete genomes of vaccine strains and reference strains from GenBank, the genetic 
relationship showed that samples from this study were grouped in a different clade than the 
vaccine strains (Fig. 4, clade A and B). This suggests that there are additional sequence 
differences in other parts of the genome compared to vaccine strains. It may indicate that the 
partial gG, TK and ICP4 genes investigated in this study were not optimal for differentiating 
between field and vaccine viruses for currently circulating ILTVs in Sweden. However, the 
reference strain “USDA reference”, which showed a nucleotide identity of 96.4% with the 
study samples and were grouped in clade C (Fig. 4) can be considered an outgroup. This might 
indicate that the complete genome of study samples and vaccine strains are very similar. In 
future studies it would be interesting to evaluate a higher number of complete genomes and 
analyse where possible differences are found when comparing field strains with vaccines. 
Coppo et al. (2013b) commented on the importance to systematically describe the virus 
genotypes that circulate in an area or country. This makes it possible to evaluate any 
vaccination strategy and to tailor a possible control strategy. As mentioned earlier, vaccination 
of hobby flocks in Sweden was started on a voluntary basis in 2006 (Engström et al., 2011; 
National Veterinary Institute, 2019b). This, together with our results suggest that ILT viruses 
from outbreaks which were presumably related to vaccine virus were circulating already before 
vaccination started in Sweden. In this case it means that vaccination itself has not necessarily 
contributed to the spread of the vaccine-related viruses. How the vaccine-related virus was 
originally introduced in Sweden is not known, but the results from this and Neff et al. (2008), 
may suggest introduction from one or a few virus pools. However, more detailed data is needed 
to support this hypothesis. 
Due to the ability to create latency it should assumingly be possible to get a positive real time 
PCR result in both healthy vaccinated chickens and healthy unvaccinated previously infected 
chickens, if they are currently shedding the virus. It would be interesting to analyse presence 
of virus in healthy vaccinated and unvaccinated chicken and to compare the genetic relationship 
with the samples in this study and vaccine virus. As one common way of introducing the ILTV 
into a hobby flock is by a latent carrier, the ILTV from the vaccinated healthy birds should 
assumingly be genetically alike the samples in this study.  
Gene by gene 
For the gG gene there were four samples with nucleotides not completely confirmed in one to 
four positions. The chromatograms for these samples showed some background noise, meaning 
that there were other DNA fragments present, which interfered with the interpretation of the 
sequence. Of these, it was only sample 18-ALD003193 that was interpreted as having a 
nucleotide that completely differed (C to G/T). As this sample also had two additional 
nucleotide changes, it suggests that it belongs to a separate virus strain or that there was too 
much background noise for the sample to produce reliable results. In sample 17-ALD007245 
there was one nucleotide that differed. However, there was another sample from this flock that 
did not have this change. This suggests that there was too much background noise for sample 
17-ALD007245 to produce reliable results.  
The sample 18-ALD002339 that differed by one nucleotide in the TK gene is suggested to 
belong to a different strain, as can be seen in the dendrogram (Fig. 2). The sample 18-ALD-
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003986 had the same nucleotide change as the vaccine strain. This sample was not present in 
the presented figures as only the sequence for the TK gene could be obtained. As this sample 
had an identical sequence as the vaccine strains it suggests that this was a potential escaped 
vaccine virus that had regained virulence. 
For the ICP4 gene it was only sample 18-ALD002509 that differed with an insert of one 
nucleotide. This sample was in the same branch as the other samples in the dendrogram. 
Genetic variation of the viruses 
This study shows that the majority of birds included in the study were infected with ILTVs 
belonging to the same group, with small genetic variation (Figures 2, 3 and 4). This suggests 
that there are only a few ILTV strains that circulate in Sweden. Engström et al. (2011) described 
that most outbreaks of ILT in Sweden were diagnosed following introduction of new chickens 
into existing flocks or following poultry shows. As ILT can become a latent infection and be 
reactivated when the bird is stressed (Guy & García, 2008), it is likely that the majority of ILT 
outbreaks are caused by trading within the non-commercial population and that this leads to 
circulation of closely related viruses. Latent infections are favoured in hobby flocks compared 
to commercial flocks, as hobby flocks often are long lived and of a multi-age structure, which 
allows the circulation of virus from latent carriers to other birds in the flock and between 
generations. Further, commercial flocks are often managed according to an “all in-all out” 
principle, which can stop circulation of pathogens present in the flock. 
There is a risk for ILTV as well as for co-infections, to transmit from hobby flocks to 
commercial flocks. As the commercial flocks in Sweden are not vaccinated against ILTV an 
infection would cause major disruption in production and animal suffering.  
Coinfections 
Respiratory co-infections appear to be common in hobby chicken flocks in some other 
countries (Blakey et al., 2019, Derksen et al., 2018, Haesendonk et al., 2014, Wunderwalt & 
Hoop, 2012, Pohjola et al., 2017). This was also demonstrated in our study although the 
occurrences of investigated co-infections were lower than in some previous studies. However, 
diagnostic methods and selection of study flocks varied between the different studies.  
APG was detected by PCR in 86% of the flocks in this study. There is very limited information 
regarding the occurrence of APG in hobby flocks in Sweden (Jansson et al., 2019), but together 
this and previous results suggest that it is a widespread pathogen among chicken hobby flocks 
with respiratory disease. The ability of APG to establish chronic clinical or subclinical 
infections and the high horizontal transmissibility between birds might be a possible 
explanation for our finding. In this study, MG and IBV showed similar occurrence among the 
sampled flocks (28%). MG has not been diagnosed in commercial flocks in recent years in 
Sweden but is known to occur in hobby flocks (National Veterinary Institute, 2019). The 
occurrence of IBV in hobby chicken flocks in Sweden is not known but IB is occasionally 
diagnosed (National Veterinary Institute, 2019). Commercial flocks, i.e. breeder chickens and 
laying hens, are vaccinated against IBV in Sweden. 
ILT outbreaks and respiratory co-infections might be associated with insufficient biosecurity. 
Derksen et al. (2018) evaluated the biosecurity in hobby flocks and found that in a majority of 
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flocks the owners did not prevent contact with wild birds and did not use dedicated shoes when 
working around their birds. Obtaining new birds to a flock is also a factor to consider. Many 
hobby flock owners in Sweden buy hatching eggs and birds and from other non-commercial 
farms and they sometimes bring home birds from swap-meets and visit poultry shows. 
Subclinically infected carrier birds may thus be introduced into the existing flock. As latent 
ILTV can be reactivated due to stress, as a co-infection, co-infections are an important factor 
to consider when evaluating factors that affect spread and outbreaks of ILTV. 
Concluding remarks 
The aim of this study was to improve the understanding of the ILT epidemiology in Sweden. 
A major limitation was the possibility to obtain representative samples from the hobby chicken 
population. The only available samples originated from chickens submitted to SVA from 
private owners, and it can be assumed that these are not fully representative of the entire non-
commercial hobby chicken population. Moreover, the vaccination status of the flocks from 
which samples were collected was unknown. To get a broader picture of the epidemiology of 
ILTV in Sweden it would be interesting to investigate ILT viruses from clinically healthy 
vaccinated and unvaccinated chickens as previously discussed, as well as the presence of 
respiratory co-infections in healthy hobby flocks. However, to obtain representative samples 
from the non-commercial poultry population in Sweden would most likely be associated with 
major difficulties as flocks are not registered and the population structure is unknown. Despite 
these limitations, this study had provided new information on ILT viruses associated with 
clinical outbreaks in non-commercial chickens. 
To conclude, when evaluating parts of the TK, gG and ICP4 genes this study suggested that 
the circulating ILTVs in Sweden are vaccine-like strains. Complete genome data from a subset 
of the samples showed similar results, however, there were additional sequence differences in 
other locations of the genome. Hence, further analyses are needed to determine whether the 
Swedish field strains originate from vaccine strains. Moreover, Swedish field strains showed 
limited genetic variation, which may speculatively suggest a common origin. This means that 
the first hypothesis (see page 1) stated for this study should be rejected. The second hypothesis 
was however more difficult to support as partial gene sequencing and complete genome 
sequencing did not show identical results (Fig. 2–4). The selection of individual genes for 
sequencing may need to be revised and additional complete genomes could provide more useful 
data. Further, coinfections were common in the flocks included in this study, with the most 
common pathogen being APG. The general occurrence of ILTV and concurrent pathogens in 
the healthy hobby chicken population is not known.  
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Infektiös laryngotrakeit (ILT) är en luftvägssjukdom som drabbar tamhöns, men även fasaner, 
påfåglar och kalkoner i viss utsträckning. Sjukdomen kan orsaka stort lidande hos fåglarna med 
akuta kliniska tecken från luftvägarna, som kan variera från rinnande ögon och näbb till mer 
allvarliga tecken som andfåddhet och upphostningar av blodigt slem. I värsta fall kan slemmet 
täppa till luftstrupen och fågeln dör. Förutom lidandet för djuren orsakar sjukdomen också ett 
stort produktionsbortfall, såsom minskad äggläggning och försenad tillväxt.  
ILT kan skapa en så kallad latent infektion, vilket betyder att smittämnet ligger vilande i 
kroppen efter det att fågeln tillfrisknat. Det finns risk att viruset aktiveras igen om fågeln blir 
stressad, t ex vid miljöombyte, äggläggningsstart eller vid utbrott av annan sjukdom. En höna 
visar inte utanpå om den bär på en latent infektion. Det innebär att en höna som bär på ett 
vilande ILT-virus och introduceras till en tidigare frisk flock, kan smitta den friska flocken med 
ILT-viruset om viruset aktiveras av stressen. 
Det går att vaccinera tamhöns mot ILT. Det finns levande försvagat vaccin, vilket innebär att 
vaccinet härmar en naturlig infektion men utan att orsaka sjukdom. Studier har visat att om 
vaccinationen inte utförs korrekt kan det försvagade vaccinviruset återfå sin sjukdomsfram-
kallande förmåga. Det har lett till att nya virusstammar, alltså nya typer av viruset som är släkt 
med vaccinviruset, har börjat cirkulera bland höns. De nya virusstammarna kan ibland orsaka 
allvarlig sjukdom.  
I stora delar av världen är de nya stammarna som uppkommer från vaccinvirus ett stort 
problem. I Sverige är ILT en ovanlig sjukdom bland de kommersiella besättningarna. Utbrott 
har diagnosticerats sedan slutet av 1990-talet i flockar med hobbyhöns. Den ursprungliga källan 
till de ILT-virus som orsakar utbrotten bland hobbyhöns i Sverige är okänt. Det utförs sällan 
vaccination mot ILT i kommersiella flockar, men sedan 2006 används vaccin mot ILT i vissa 
hobbyhönsflockar.  
Syftet med den här studien var att undersöka om de ILT-virus som smittat hobbyhöns i Sverige 
de senaste åren (2017–2018) är släkt med de virus som används som vaccin, samt att undersöka 
om höns med ILT också har andra luftvägssjukdomar samtidigt som ILT. För att ta reda på det 
analyserades ILT-virusets arvsmassa i prover från hobbyhöns som haft kliniska tecken från 
luftvägarna och som skickats till Statens Veterinärmedicinska Anstalt för analys. ILT var 
konstaterad i de flesta fallen. Arvsmassan i dessa prover jämfördes med arvsmassan från 
vaccinvirus för att påvisa likheter och skillnader. I samma prover undersöktes även före-
komsten av tre andra smittämnen som kan orsaka luftvägssjukdomar hos tamhöns.  
Vår studie visade att arvsmassan hos ILT-virus från hobbyhönsproverna var sinsemellan 
mycket lika. Detta talar för att de ILT-virus som cirkulerar i Sverige har ett gemensamt 
ursprung. Dessutom var arvsmassan hos ILT-virus från hobbyhönsen och vaccinvirus lika 
varandra, vilket kan tala för att ILT-virus hos svenska hobbyhöns kan ha sitt ursprung från 
vaccinvirus. Vår slutsats är dock att ytterligare analyser behöver göras. Vad som också 
framkommit är att viruset hos hobbyhönsen ser ut att vara väldigt likt äldre virus som 
cirkulerade innan vaccinationen av hobbyhöns påbörjades i Sverige. 
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Resultaten visade också att proverna förutom ILT-virus ofta innehöll arvsmassa från andra 
smittämnen som kan orsaka luftvägssjukdomar. Det vanligaste smittämnet var en bakterie 
(Avibacterium paragallinarum) som orsakar sjukdomen infektiös coryza. Totalt 83 % av de 
undersökta flockarna bar på denna bakterie. Infektiös coryza kan, liksom ILT, spridas med 
kroniskt smittade friska smittbärare. En femtedel av de undersökta hobbyhönsflockarna i vår 
undersökning hade även arvsmassa från smittämnena infektiöst bronkitvirusvirus och bakterien 
Mycoplasma gallisepticum. 
Resultaten från den här studien bidrar till ökad förståelse för sjukdomen ILTs ursprung och 
orsak i Sverige, vilket är viktigt för att kunna vidta åtgärder för att minska sjukdomens framtida 
framfart i Sverige.   
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